Envestnet Asset Management
COLL icon

Envestnet Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Envestnet Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Buy
80,112
+19,064
+31% +$651K ﹤0.01% 2879
2026
Q1 		$2.02M Buy
61,048
+25,362
+71% +$1.07M ﹤0.01% 3006
2025
Q4 		$1.65M Sell
35,686
-13,191
-27% -$552K ﹤0.01% 2967
2025
Q3 		$1.71M Buy
48,877
+4,143
+9% +$144K ﹤0.01% 2988
2025
Q2 		$1.32M Buy
44,734
+13,842
+45% +$395K ﹤0.01% 3097
2025
Q1 		$922K Buy
30,892
+6,554
+27% +$200K ﹤0.01% 3261
2024
Q4 		$697K Buy
24,338
+152
+0.6% +$5.03K ﹤0.01% 3391
2024
Q3 		$935K Buy
24,186
+3,692
+18% +$132K ﹤0.01% 3172
2024
Q2 		$660K Buy
20,494
+3,465
+20% +$120K ﹤0.01% 3296
2024
Q1 		$661K Sell
17,029
-2,951
-15% -$103K ﹤0.01% 3276
2023
Q4 		$615K Buy
19,980
+2,020
+11% +$50.6K ﹤0.01% 3214
2023
Q3 		$401K Buy
17,960
+2,119
+13% +$48.3K ﹤0.01% 3365
2023
Q2 		$340K Sell
15,841
-1,218
-7% -$27.7K ﹤0.01% 3422
2023
Q1 		$409K Sell
17,059
-614
-3% -$16.3K ﹤0.01% 3281
2022
Q4 		$410K Sell
17,673
-28
-0.2% -$565 ﹤0.01% 3214
2022
Q3 		$284K Buy
17,701
+1,599
+10% +$28.2K ﹤0.01% 3382
2022
Q2 		$285K Buy
16,102
+74
+0.5% +$1.25K ﹤0.01% 3388
2022
Q1 		$326K Buy
16,028
+3,058
+24% +$57.8K ﹤0.01% 3405
2021
Q4 		$242K Sell
12,970
-4,340
-25% -$84.6K ﹤0.01% 3548
2021
Q3 		$342K Buy
17,310
+2,631
+18% +$56.9K ﹤0.01% 3214
2021
Q2 		$347K Buy
14,679
+621
+4% +$14.3K ﹤0.01% 3200
2021
Q1 		$333K Sell
14,058
-258
-2% -$6.13K ﹤0.01% 3081
2020
Q4 		$287K Buy
14,316
+3,289
+30% +$64.2K ﹤0.01% 2945
2020
Q3 		$230K Buy
11,027
+173
+2% +$3.12K ﹤0.01% 2848
2020
Q2 		$190K Buy
10,854
+630
+6% +$12.3K ﹤0.01% 2885
2020
Q1 		$167K Buy
+10,224
New +$211K ﹤0.01% 2767
2017
Q2 		– Sell
-70
Closed -$1K – 3057
2017
Q1 		$1K Hold
70
– – ﹤0.01% 3045
2016
Q4 		$1K Buy
+70
New +$1.16K ﹤0.01% 3025

Other funds holding COLL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Envestnet Asset Management's COLL Position: Q2 2026 in Review

Envestnet Asset Management increased its Collegium Pharmaceutical (COLL) stake by 31% in Q2 2026, buying an estimated $651K and bringing the position to 80,112 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Envestnet Asset Management first reported a position in COLL in Q4 2016 and has held it in 28 quarters since. 74 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Envestnet Asset Management held 80,112 shares of Collegium Pharmaceutical worth $2.9M as of Q2 2026.
  • Envestnet Asset Management bought 19,064 Collegium Pharmaceutical shares in Q2 2026, an estimated $651K.
  • Collegium Pharmaceutical made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2879 holding.
  • Envestnet Asset Management first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 28 quarters since.
  • 74 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.